SPDR S&P Biotech ETF $XBI Stake Reduced by Marotta Asset Management

Marotta Asset Management cut its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 11.2% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 65,558 shares of the exchange traded fund’s stock after selling 8,302 shares during the period. SPDR S&P Biotech ETF accounts for approximately 1.5% of Marotta Asset Management’s investment portfolio, making the stock its 24th largest holding. Marotta Asset Management’s holdings in SPDR S&P Biotech ETF were worth $7,993,000 at the end of the most recent reporting period.

A number of other hedge funds also recently added to or reduced their stakes in XBI. Capital A Wealth Management LLC acquired a new position in shares of SPDR S&P Biotech ETF during the second quarter valued at $26,000. Johnson Financial Group Inc. bought a new position in shares of SPDR S&P Biotech ETF during the second quarter worth about $31,000. Twin Peaks Wealth Advisors LLC acquired a new stake in shares of SPDR S&P Biotech ETF in the 2nd quarter worth about $32,000. Davis Capital Management acquired a new stake in shares of SPDR S&P Biotech ETF in the 3rd quarter worth about $35,000. Finally, Halbert Hargrove Global Advisors LLC bought a new stake in SPDR S&P Biotech ETF in the 3rd quarter valued at about $40,000.

SPDR S&P Biotech ETF Stock Down 1.7%

SPDR S&P Biotech ETF stock opened at $120.31 on Friday. SPDR S&P Biotech ETF has a 52-week low of $66.66 and a 52-week high of $132.09. The firm has a market capitalization of $8.04 billion, a price-to-earnings ratio of 11.47 and a beta of 0.93. The firm has a 50-day moving average price of $125.37 and a two-hundred day moving average price of $116.13.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.